iShares Neuroscience and Healthcare ETF (IBRN) Holdings $25.67 +0.53 (+2.11%) As of 01/21/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatings Top 50 IBRN HoldingsRankCompanyCurrent PriceWeightShares Held1NBIXNeurocrine Biosciences$145.88+1.8%4.47%1,2482SK Biopharmaceuticals Co., Ltd.N/A4.38%2,2303ARGXargenx$647.39+1.1%4.16%2574SUPNSupernus Pharmaceuticals$38.58+2.2%4.15%4,3045ITCIIntra-Cellular Therapies$126.50+0.2%4.13%1,8926SRRKScholar Rock$44.88+4.1%4.11%3,6707ACADACADIA Pharmaceuticals$17.89+1.8%4.04%9,2578CPRXCatalyst Pharmaceuticals$22.92+0.6%4.00%7,2649BIIBBiogen$140.98+0.3%3.98%1,01410PTCTPTC Therapeutics$45.25+3.2%3.98%3,330 Get the Latest News and Ratings for IBRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. 11SRPTSarepta Therapeutics$116.79-1.0%3.95%1,24812ALKSAlkermes$30.10+2.1%3.82%5,08513XENEXenon Pharmaceuticals$38.98+1.2%3.77%3,74414H. Lundbeck A/SN/A3.53%23,45215EWTXEdgewise Therapeutics$27.39+4.3%3.47%4,90816IARTIntegra LifeSciences$25.12+4.2%3.40%5,79217DYNDyne Therapeutics$14.55+3.0%3.35%5,42218BHVNBiohaven$39.09+4.0%3.34%3,57119PRAXPraxis Precision Medicines$78.26+10.9%3.00%1,50820AVDLAvadel Pharmaceuticals$7.90+1.9%2.12%7,71721AVXLAnavex Life Sciences$9.85+6.9%2.07%7,18522Neuren Pharmaceuticals LimitedN/A1.93%9,84323BioArctic AB (publ)N/A1.61%3,41024AXGNAxoGen$18.97+4.9%1.56%3,63125PRTAProthena$14.11+2.5%1.52%3,92026CAPRCapricor Therapeutics$14.06+2.6%1.26%3,49727SGMOSangamo Therapeutics$1.13+3.7%1.07%17,42228ANNXAnnexon$4.17-0.7%1.05%7,81729ZVRAZevra Therapeutics$8.15+1.2%1.00%4,64530DNTHDianthus Therapeutics$21.66+8.3%0.94%1,67631TRDAEntrada Therapeutics$13.06+2.9%0.86%1,90032CLPTClearPoint Neuro$18.42+22.5%0.85%2,09233NGNENeurogene$16.62+0.1%0.82%1,41534RAPPRapport Therapeutics$13.27+4.6%0.74%1,52935MedinCell S.A.N/A0.72%1,57236TSHATaysha Gene Therapies$1.530.61%13,44337VNDAVanda Pharmaceuticals$4.51+3.4%0.60%4,83238VYGRVoyager Therapeutics$5.22+3.0%0.58%3,95339Microport Neuroscientific Co Common Stock Usd.00002N/A0.53%18,00040SanBio Company LimitedN/A0.53%4,300Trump currency shock imminent (Ad)Trump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launched a $1.9 trillion move against the Fed. What comes next could have dramatic consequences.Read about it here.41ABEOAbeona Therapeutics$5.19-0.6%0.50%3,44342CTNMContineum Therapeutics$11.28-9.3%0.46%1,20743AMLXAmylyx Pharmaceuticals$3.45-4.2%0.38%3,78544LRMRLarimar Therapeutics$3.43+2.7%0.33%3,23945ALECAlector$1.73+1.2%0.30%6,60346NVRONevro$4.68+2.3%0.30%3,09447SLDBSolid Biosciences$3.26-0.3%0.30%2,84748Cellivery Therapeutics Inc Ordinary SharesN/A0.25%3,56549Idorsia LtdN/A0.25%10,58650SAVACassava Sciences$2.62-4.7%0.23%3,657 Geographic ExposureUnited States69.1%Ireland6.9%Korea, Republic of4.8%Canada4.0%Denmark3.4%Virgin Islands, British3.4%New Zealand2.0%Sweden1.6%France0.7%Japan0.6%Cayman Islands0.5%Switzerland0.2%Currency ExposureUSD86.0%KRW4.8%DKK3.4%AUD2.0%SEK1.7%EUR0.7%JPY0.6%HKD0.5%CHF0.3%Sector ExposureHealth Care66.9%Industry ExposureBiotechnology59.8%Health Care Equipment & Supplies5.2%Pharmaceuticals2.0%SubIndustry ExposureBiotechnology54.7%Health Care Equipment3.4%Pharmaceuticals2.2%Health Care Supplies1.8%Coupon Exposure0-2100.0% Related Companies and Tools Related Companies BEDZ Holdings NVIR Holdings SOLR Holdings GLIF Holdings IVEG Holdings ARVR Holdings IRHG Holdings LMBO Holdings THNR Holdings EMTY Holdings This page (NYSEARCA:IBRN) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
